Electrochemical dephosphorylation technique for treating Alzheimer's disease and use thereof
11020594 · 2021-06-01
Assignee
Inventors
- JUNG-CHIH CHEN (Hsinchu, TW)
- I-Chiu Li (Hsinchu, TW)
- Kun-Che Li (Hsinchu, TW)
- Ching-Cheng Chuang (Hsinchu, TW)
- Mei-Lan Ko (Hsinchu, TW)
- Hsin-Yu Chen (Hsinchu, TW)
- Chia-Hsuan Chang (Hsinchu, TW)
- Hsin-Yi Tsai (Hsinchu, TW)
- Chien-Chih Hsu (Hsinchu, TW)
Cpc classification
A61N1/0536
HUMAN NECESSITIES
International classification
Abstract
The invention relates to an electrochemical dephosphorylation technique for treating Alzheimer's disease and a use thereof. It comprises a gold electrode provided with a negative potential of −0.2 V to −0.6 V on a surface thereof.
Claims
1. A method for treating Alzheimer's disease comprising: forming an electrochemical dephosphorylation electrode consisting of a gold electrode member having a planar contour; applying said electrochemical dephosphorylation electrode to a region of a patient corresponding to the patient's hippocampus, wherein the hippocampus has neurofibrillary tangles and neuritic plaques, and charging a surface of said gold electrode member with a negative potential in a range between −0.2V and −0.6V and applying said negative potential for a predetermined time to the patient's hippocampus, thereby dephosphorylating Tau proteins aggregated in the hippocampus as a treatment of Alzheimer's disease.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT
(10) The present invention relates to an electrochemical dephosphorylation electrode for treating Alzheimer's disease and a method for treating Alzheimer's disease by use of the electrochemical dephosphorylation electrode.
(11) The method comprises the steps of applying an electrochemical dephosphorylation electrode to a hippocampus region having neurofibrillary tangles and neuritic plaques to dephosphorylate Tau proteins of an individual in need. The electrochemical dephosphorylation electrode comprises a gold electrode provided with a negative potential of −0.2 V to −0.6 V on a surface thereof.
(12) Hereinafter, an exemplary embodiment of the present invention will be described in detail with reference to the accompanying drawings.
Example 1
(13) 1. Preparation of Gold Electrode
(14) A crystal oscillator (Frequency oscillator, Model: CHI-405C) (Crystal, CH instruments, USA, Catalog: 151215) was used in this example. The fundamental frequency of the quartz crystal was 7.995 MHz. Both sides of the quartz crystal were respectively provided with a gold thin film which was deposited on a top of the crystal as a working electrode.
(15) 2. Preparation of Polyaniline (PANI) Film for Testing the Gold Electrode
(16) An electrochemical quartz crystal microbalance (EQCM) (CH instruments, USA, model CHI-405C) was used in this example to detect the effect of a gold electrode. A polyaniline (PANI) film was prepared by a potentiostatic method and modified on the gold electrode to serve as a dephosphorylated carrier, and its electrochemical properties were tested. When preparing the PANI film, the most suitable parameters were acquired by the potentiostatic method. The amount of charge was converted according to the change of current with time, and the mass and thickness of the PANI film were converted by the frequency variation. Since the PANI film has a positive charge, the phosphates were adsorbed on the positively charged PANI film after phosphoric acids were added. Then, the change of the negative potential was used to test whether the phosphates were detached from the PANI film, and the phosphate elimination rate was instantaneously converted by the frequency variation. In preparing the PANI film by the potentiostatic method, the potential was set at 0.8 V, the sensitivity was 0.001 A/V, and the time was about 200 seconds. As shown in
(17) 3. Using the PANI Film As a Carrier Test Phosphate Adsorption and Release at Different Phosphate Concentrations
(18) A potential of 0.3 V was applied to the PANI film to cover phosphates on the PANI film. If the concentration of phosphate increases, the PANI film adsorbed more phosphates. By applying various negative potentials, phosphates were removed from the PANI film. The phosphate adsorption and release were tested at three phosphate concentrations of 5 μM, 500 nM, and 5 nM.
(19) Referring to
Example 2
(20) In order to simulate the actual status of hyper-phosphorylated Tau protein (purchased from Abcam, ab 84700) in humans, whether the phosphates could be removed from Tau proteins by the potentiostatic method was evaluated.
(21) The PANI film was prepared by the potentiostatic method at a constant potential of 0.8 V and a frequency of −3200 Hz, and the rate at which the Tau proteins detached from the PANI film under different potentials was observed.
(22) According to Table 1, after 10 ng/mL Tau proteins (dissolved in 0.1 M PBS buffer solution at pH 7.4) were deposited on the PANI film at 4° C. for 4 hours, the mass converted from the frequency was 770.5 ng. Then, a negative potential of −0.4 V was applied to the PANI film for 10 seconds, and the rate at which Tau proteins detached from the PANI film was evaluated. The detached proteins were measured to be 362 Hz, so the amount of proteins remaining on the PANI film were about 285.42 ng. In addition, the application of a negative potential was stopped to assess whether the Tau proteins were reabsorbed by the positively charged PANI film. After 3 minutes, the frequency was detected to decrease to −60 Hz, and the Tau protein content on the PANI film was increased to 365.82 ng. Finally, a negative potential of −0.4 V was applied to the PANI film for 20 seconds, and the Tau proteins on the PANI film were completely detached from the film. Since parts of the components on the PANI film are detached together with the Tau proteins, the mass of the PANI film became a negative value. From the result, it is known that Tau protein release rate was 26.379 Hz/s, which was very fast.
(23) TABLE-US-00001 TABLE 1 Potential (V) Time (s) Delta frequency (Hz) Delta Mass (ng) 0 14000 −575 770.5 −0.4 10 362 285.42 0 180 −60 365.82 −0.4 20 429.37 −209.54
(24) In order to use a scanning electron microscope (SEM) (JSM-7401F) to observe the phosphorylation of Tau proteins on the PANI film at the negative potential of −0.4 V, 2.5% glutaraldehyde was used as a protein fixing agent for fixation of Tau proteins at a temperature of 4° C. for 1-2 hours, and then proteins were rinsed with a 0.1 M PBS buffer solution (pH 7.4). Next, the fixed Tau proteins were sequentially and respectively placed in 60%, 75%, 85%, 95%, 100% alcohol for 5 minutes for dehydration. After the dehydration procedure, Tau proteins were placed in an oven, and a gold electrode attached with a sample to be tested was adhered to a copper sheet and placed in a vacuum pump to evacuate. The SEM equipment was equipped with an energy dispersive spectrometer (EDS) for simultaneously qualitative and semi-quantitative analysis of the elemental material of the micro-zone of the sample.
(25) Referring to
(26) Additionally, the results of qualitative and semi-quantitative analysis of the elemental material of the micro-zone of the sample conducted by the EDS method are disclosed in
(27) TABLE-US-00002 TABLE 2 Phosphorylation Dephosphorylation Element Weight (%) Atomic (%) Weight (%) Atomic (%) C K 50.92 81.10 52.85 83.53 N K 0.74 1.01 0.46 0.62 O K 9.51 11.37 8.69 10.31 P K 2.12 1.31 1.05 0.64 S K 3.29 1.97 2.70 1.60 Au K 33.42 3.25 34.26 3.30
Example 3
(28) In this example, 10 ng/mL Tau proteins (dissolved in 0.1 M PBS buffer solution at pH 7.4) were deposited on the PANI film at 4° C. for 4 and 24 hours, respectively, to analyze the structure changes of the PANI film in the surface after adsorbed Tau protein at different times.
(29) Referring to
(30) In order to analyze the accumulations of Tau proteins before and after phosphorylation by SEM, 2 μl of 1 ng/mL GSK-3β (Merck, product number 361524) and 1 μl of 91 μM adenosine triphosphate (ATP) (SIGMA A26209) were added to 1000 μl of PBS buffer solution to form a mixed solution. Then, the mixed solution was added to a PANI film on which the Tau protein was deposited, and the protease was added for reaction at a temperature of 30° C. to phosphorylate the Tau protein. Furthermore, a negative potential of −0.4 V was applied to the PANI film, and the accumulation of Tau proteins on the PANI film was observed and compared with the phosphorylated protein.
(31) Referring to
(32) Referring to
(33) The results of the qualitative and semi-quantitative analysis of the elemental material of the sample to be tested using the EDS method are shown in Table 3. Phosphoric acid content was significantly reduced by dephosphorylation by EDS, which indicates that ATPs and some Tau proteins can be released by applying a negative potential of −0.4 V.
(34) TABLE-US-00003 TABLE 3 Phosphorylation Dephosphorylation Element Weight (%) Atomic (%) Weight (%) Atomic (%) P K 36.62 62.59 9.72 27.16 S K 14.75 24.35 14.70 39.65 Au K 48.63 13.07 75.58 33.19
(35) Compared with the technique available now, the present invention achieves the purpose of dephosphorylated Tau proteins by electrode treatment. In practical applications, the electrode can be placed in the vicinity of the hippocampus which is particularly severely atrophic to remove the phosphates of the phosphorylated Tau protein by a specific negative potential and reduce neurofibrillary tangles and neuritic plaques caused by the accumulation of phosphorylated Tau proteins. The present invention also avoids the persistent hyper-phosphorylation of the Tau protein and thus achieves the therapeutic effect of Alzheimer's disease.